申请人:Kaken Shoyaku Co., Ltd.
公开号:EP0931544A2
公开(公告)日:1999-07-28
This invention relates to an NF-κB activity inhibitor which contains alkaloids originated from a plant belonging to the genus Stephania of the family Menspermaceae, derivatives thereof and salts thereof, as the active components, to an agent for use in the treatment and prevention of diseases upon which the NF-κB activity inhibiting action is effective and to an inhibitor of the expression of related genes. Since said active components exert an action to inhibit transcription of DNA having an NF-κB recognition sequence by inhibiting the activity of NF-κB, the drug of the present invention can inhibit expression of genes of certain substances such as cytokines, inflammatory cytokine receptor antagonists, MHC class I, MHC class II, β2 microglobulin, immunoglobulin light chain, serum amyloid A, angiotensinogen, complement B, complement C4, C-myc gene, HIV, SV40, CMV, adenovirus and the like, so that the inventive drug is useful in treating and/or preventing various diseases in which these substances are taking roles.
本发明涉及一种NF-κB活性抑制剂,其活性成分含有源自一种属于孟婆子科斯蒂芬尼亚属植物的生物碱、其衍生物及其盐类,涉及一种用于治疗和预防NF-κB活性抑制作用有效的疾病的药物,还涉及一种相关基因表达抑制剂。MHCⅠ类、MHCⅡ类、β2微球蛋白、免疫球蛋白轻链、血清淀粉样蛋白A、血管紧张素原、补体B、补体C4、C-myc基因、HIV、SV40、CMV、腺病毒等,因此本发明药物可用于治疗和/或预防这些物质起作用的各种疾病。